TABLE 2.
Antigensa | Immunity routeb | Challenge routeb | Outcome by homologous challengec | Outcome by heterologous challenged | References |
Inactivated vaccine | |||||
O78 | SC, IM, IP | IM or IV | Protective | Not protective | Deb and Harry, 1976 |
O2 | SC, IM | SC | Protective | Not protective | Deb and Harry, 1978 |
O1 | SC | Air sac | Protective | Not protective | Gyimah and Panigrahy, 1985 |
O1, O2, and O78 | IM | N/A | Protective | N/T | Panigraphy et al., 1984 |
O2; O78 | SC, SC | SC; SC | Protective | Protective; not protective |
Melamed et al., 1991 |
O2, O78, and O35 | SC | IT | Protective | Not protective | Rosenberger et al., 1985 |
Subunit vaccines | |||||
Aerobactin | IM | Aerosol | Protective | Not protective | Le Roy et al., 1995 |
IROMPs | IV | Air sac | Protective | N/T | Bolin and Jensen, 1987 |
SRP | SC | IV | Protective | Protective | Russo et al., 2003 |
Pilus | SC | Air sac | Protective | N/T | Gyimah and Panigrahy, 1985 |
FimA | IM | Air sac | Protective | Protective | van den Bosch et al., 1993 |
FimH | IM | Air sac or aerosol | Not protective | Not protective | Kariyawasam et al., 2002 |
PapG | IM | Air sac | Protective | Protective | Kariyawasam et al., 2002 |
IutA | IM | Air sac | Protective | Protective | Kariyawasam et al., 2002 |
Iss | IM | Air sac | Protective | Protective | Lynne et al., 2012 |
rOmpA and rFliC, recombinant GroEL | IM | Sterile water | Protective | Not protective | Bao et al., 2013 |
Live attenuated vaccines | |||||
Non-pathogenic E. coli O78 | Aerosol | Aerosol | Not protective | N/T | Azeem et al., 2017 |
Non-pathogenic piliated E. coli (BT-7) | Aerosol, drinking water | IT | N/A | Protective | Ghunaim et al., 2014 |
ΔcarAB | IM | IM | N/A | Protective | Frommer et al., 1994 |
Δcya Δcrp | Oral | IT | Protective | N/T | Kwaga et al., 1994 |
Δcya Δcrp | Spray, Oral | IT | Protective | N/T | Roland et al., 1999 |
ΔgalE | Spray | Aerosol | Protective | N/T | Peighambari et al., 2002 |
DE17ΔaroAΔluxS | Spray | Aerosol | Protective | Not protective | Kariyawasam et al., 2004 |
ΔpurA | IM | Aerosol | Protective | Protective | Holden et al., 2014 |
ΔaroA | Spray | Aerosol | Not protective | Not protective | Kariyawasam et al., 2004 |
O78:K80 | Spray | Aerosol | Protective | Not protective | Kariyawasam et al., 2004 |
Other vaccines | |||||
Bacterial ghost | Spray, IM | Air sacs, IM | Protective | Not protective | Ebrahimi-Nik et al., 2018; Hu et al., 2019 |
Salmonella delivery FimA, OmpC, O78 | Oral gavage | IM or air sac | Protective | Protective | Han et al., 2018 |
Lactobacillus strains expressing PapA, PapG, IutA, CS31A | Intragastric | Oral | Protective | Not protective | Ma S. T. et al., 2018 |
Outer membrane vesicles | IM | Air sac | Protective | Not protective | Wang et al., 2019 |
aSRP, siderophore receptor protein; IROMPs, iron-regulated outer membrane proteins; Iss, increased serum survival protein.
bIV, intravenous; IM, intramuscular; SC, subcutaneous; IP, intraperitoneal; IT, intratracheal; N/A, not applicable or not available.
cN/A, not applicable or not available.
dN/T, not tested; N/A, not applicable or not available.